Conjugated hyperbilirubinemia presenting in first fourteen days in term neonates

Fang Kuan Chiou1, Christina Ong1, Kong Boo Phua1

  • 1Gastroenterology Service, Paediatric Medicine, KK Women's and Children's Hospital, Singapore 229899, Singapore.

Insights

Early-onset conjugated hyperbilirubinemia (ECHB) in neonates is often due to secondary liver injury, particularly in unwell infants. Biliary atresia can present atypically in well infants with ECHB.

Area of Science:

  • Neonatology
  • Pediatric Gastroenterology
  • Hepatology

Background:

  • Conjugated hyperbilirubinemia (CHB) in neonates requires prompt diagnosis.
  • Early-onset CHB (ECHB) presents within 14 days of life and necessitates understanding its diverse etiologies.
  • Differentiating ECHB from late-onset CHB (LCHB) is crucial for appropriate management.

Purpose of the Study:

  • To elucidate the causes and clinical features of early-onset conjugated hyperbilirubinemia (ECHB) in term neonates.
  • To compare the characteristics of ECHB with late-onset CHB (LCHB).

Main Methods:

  • Retrospective review of term infants with CHB (conjugated bilirubin [CB] >15% of total bilirubin and CB ≥25 μmol/L) within 28 days of life.
  • Categorization into ECHB (within 14 days) and LCHB (15-28 days).
  • Analysis of clinical presentation, etiology, and outcomes.

Main Results:

  • Of 117 infants, 65 had ECHB and 52 had LCHB.
  • ECHB infants were more likely to be clinically unwell (80.0% vs 42.3%) and have non-hepatic causes (73.8% vs 44.2%).
  • Multifactorial liver injury and sepsis were common in unwell ECHB infants; biliary atresia was frequent in well ECHB infants, often without pale stools.

Conclusions:

  • Secondary hepatic injury is the primary cause of ECHB.
  • Biliary atresia can manifest as ECHB in otherwise well neonates, lacking typical symptoms like pale stools.
Abstract

Related Concept Videos

Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
4.3K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
276
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
937
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.0K
Lifecycle of Erythrocytes01:22

Lifecycle of Erythrocytes

Erythrocytes, also known as red blood cells, constantly move through blood capillaries. As a result, they damage their plasma membrane due to the continuous friction. Typically, after 100 to 120 days, erythrocytes become rigid and fragile as they wear out. As they pass through small vessels in the spleen and liver, they can get trapped and break apart into fragments.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups....
5.5K
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.1K